Patent · US Active

Use of protein SATB2 as a marker for colorectal cancer

US8465934B2 · kind B2 · utility

1Cited by

0References

6Claims

0Family size

Assignee

Atlas Antibodies AB · SE

Inventors

Mathias Uhlen · Uppsala, SE
Fredrik Pontén · Uppsala, SE

Key dates

Filing date	Jul 6, 2012
Grant date	Jun 18, 2013
Priority date	—
Expiry date	Jul 6, 2032

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/4703
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention provides new methods, means and uses in connection with detection, characterization and prognosis of colo-rectal cancer, via the identification of the SATB2 protein as a marker for this cancer type.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.